The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors that: (1) starting in January 2020, KORU ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company’s net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Repro Med Systems, Inc. Securities Litigation
Mar 29, 2021 | Repro Med Systems Inc. Common Stock NASDAQ: KRMD | Case Status: Filed
If you purchased a significant amount of shares of Repro Med Systems Inc. Common Stock (NASDAQ: KRMD), you have certain options. Investors should contact us.
Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Repro Med Systems Inc. Common Stock
First Identified Complaint
James Humenik, Jr., et al. v. Repro Med Systems, Inc., et al.
First Identified Complaint Filings
|#||Document Title||Filing Date|
|1||Class Action Complaint for Violations of the Federal Securities Laws||March 26th, 2021|
|2||U.S. District Court Civil Docket||March 26th, 2021|